AGC Biologics to Expand Biopharmaceutical CDMO Capacity ...Middle East

PR Newswire - News
AGC Biologics to Expand Biopharmaceutical CDMO Capacity
SEATTLE, Nov. 30, 2020 /PRNewswire/ -- AGC Biologics announced that it will increase the production capacity of its Copenhagen facility. AGC Biologics will construct a new building on land adjacent to its current Copenhagen site, adding production floors with 2000L single-use bioreactors,...

Hence then, the article about agc biologics to expand biopharmaceutical cdmo capacity was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AGC Biologics to Expand Biopharmaceutical CDMO Capacity )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News